PubMed:21921061 / 95-301
Annnotations
ICD10
{"project":"ICD10","denotations":[{"id":"T1","span":{"begin":79,"end":102},"obj":"http://purl.bioontology.org/ontology/ICD10/G61.0"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
GlycoBiology-FMA
{"project":"GlycoBiology-FMA","denotations":[{"id":"_T2","span":{"begin":44,"end":54},"obj":"FMAID:167180"},{"id":"_T3","span":{"begin":164,"end":176},"obj":"FMAID:82816"},{"id":"_T4","span":{"begin":164,"end":176},"obj":"FMAID:196811"},{"id":"_T5","span":{"begin":180,"end":191},"obj":"FMAID:196811"},{"id":"_T6","span":{"begin":180,"end":191},"obj":"FMAID:82816"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
uniprot-human
{"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":201,"end":204},"obj":"http://www.uniprot.org/uniprot/P56915"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
GO-MF
{"project":"GO-MF","denotations":[{"id":"T2","span":{"begin":44,"end":54},"obj":"http://purl.obolibrary.org/obo/GO_0003823"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
GO-CC
{"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":201,"end":204},"obj":"http://purl.obolibrary.org/obo/GO_0032593"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
Allie
{"project":"Allie","denotations":[{"id":"SS1_21921061_1_0","span":{"begin":79,"end":102},"obj":"expanded"},{"id":"SS2_21921061_1_0","span":{"begin":104,"end":107},"obj":"abbr"},{"id":"SS1_21921061_1_1","span":{"begin":180,"end":199},"obj":"expanded"},{"id":"SS2_21921061_1_1","span":{"begin":201,"end":204},"obj":"abbr"}],"relations":[{"id":"AE1_21921061_1_0","pred":"abbreviatedTo","subj":"SS1_21921061_1_0","obj":"SS2_21921061_1_0"},{"id":"AE1_21921061_1_1","pred":"abbreviatedTo","subj":"SS1_21921061_1_1","obj":"SS2_21921061_1_1"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T2","span":{"begin":79,"end":102},"obj":"Disease"},{"id":"T3","span":{"begin":104,"end":107},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
GlyCosmos15-MONDO
{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T2","span":{"begin":79,"end":102},"obj":"Disease"},{"id":"T3","span":{"begin":104,"end":107},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":206},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}
GlyCosmos15-Sentences
{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":206},"obj":"Sentence"}],"text":"It is now emerging the new concept that the antibodies from some patients with Guillain-Barré syndrome (GBS) recognize an antigenic epitope formed by two different gangliosides, a ganglioside complex (GSC)."}